Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024
... Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Clinical trials scenario. This report provides top line data relating to the clinical trials on Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) . Report includes an overview of ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
... (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Seasonal Influenza - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024
... Deficiency) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A (Factor VIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Cognitive Assessment And Training Global Market Report 2024
... By Application: Clinical Trials; Learning; Research Covering: Pearson plc; Quest Diagnostics; Koninklijke Philips N.V; Cogstate Ltd; CogniFit Ltd Cognitive Assessment And Training Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Global In Silico Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 5.08 billion by 2029, growing at a CAGR of 6.89% during the forecast period (2024-2029). The unanticipated spread of COVID-19 significantly influences the in silico clinical trials market. Even though ... Read More
-
Clinical Trial Management Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... Key Highlights The COVID-19 pandemic significantly impacted the clinical trial management market. The pandemic restrictions implemented to control the virus's spread disrupted ongoing clinical trials, causing delays and cancellations of trials in the early pandemic ... Read More
-
Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... billion by 2029, growing at a CAGR of 7.42% during the forecast period (2024-2029). COVID-19 pandemic had a significant impact on the market studied. According to a study that was published in the American Chemical ... Read More
-
Clinical Trial Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... USD 1.63 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029). Clinical trials are used in the development and testing of vaccines and other therapeutics; they have been essential in ... Read More
-
Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 5.91% during the forecast period (2024-2029). The COVID-19 pandemic tremendously impacted the market for clinical trials, as there has been a rising focus on developing new therapeutics ... Read More
-
Global Virtual Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 14.88 billion by 2029, growing at a CAGR of 9.34% during the forecast period (2024-2029). The COVID-19 pandemic has shut down population movements and transport systems across large parts of the world, ... Read More
-
In Silico Clinical Trials Global Market Report 2024
... PharmaceuticalCovering: Dassault Systemes SE; Clarivate plc; Evotec AG; Evidera; Certara Inc. In Silico Clinical Trials Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they ... Read More
-
Clinical Trial Supplies Global Market Report 2024
... III; Phase IV3) By Therapeutic Use: Oncology; Central Nervous System (CNS); Cardiovascular; Infectious Disease; Metabolic Disorders 4) By End User: Pharmaceutical And Biotech companies; Contract Research Organization (CRO); Medical Device CompaniesCovering: Thermo Fisher Scientific Inc.; ... Read More
-
STXBP1 Encephalopathy
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
Innovation Waves in Immuno-oncology Therapy Development
... prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, including monoclonals, antibody-drug conjugates (ADCs), bispecific antibodies, ... Read More
-
Premature Labor (PL) -Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for PL. Marketed drugs for PL are widely genericized and the majority of drugs indicated to treat PL are beta-2 adrenergic receptor antagonists. Out of 13 drugs ... Read More
-
Asia CRO Market Research Report Forecast to 2032
... development are boosting the demand for CRO services. Moreover, the rising prevalence of chronic diseases and government support for R&D are also fueling the growth of the market. However, a lack of experienced and skilled ... Read More
-
Angelman Syndrome
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
Global Clinical Trial Software Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Clinical Trial Software industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Clinical Trial Software. The report also introduces players ... Read More
-
Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... Renub Research. Clinical trials have been a part of the medical outlook for 275 years, creating opportunities for physicians to find viable treatments for various conditions. These are studies to test new drugs, already-approved drugs, ... Read More
-
Global Anticancer Drugs Market Research Report 2024
... during the forecast period 2024-2030. North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the ... Read More
-
Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034
... RR-FL; however, follow-up remains limited. Identifying appropriate patients for CAR T-cell therapy stands out as a paramount challenge, given its expensive nature and aggressive treatment approach. The FDA has approved four CAR-Ts in different subtypes ... Read More
-
Giant-Cell Arteritis - Market Insight, Epidemiology And Market Forecast - 2034
... originates from melanocytes, pigment-producing cells, and can potentially metastasize, commonly to the liver. Ocular melanoma can be divided into uveal and non-uveal melanoma. Uveal melanoma (~95%) comprises the larger group of ocular melanoma and consists ... Read More
-
Schizophrenia- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Schizophrenia: Understanding Schizophrenia: Overview ... Read More
-
Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034
... rare and severe nonmalignant disease characterized by autoimmune destruction of early hematopoietic cells. Its global incidence rate ranges from 0.7–7.4 cases per million inhabitants per year, with higher rates in Asia compared to Europe and ... Read More
Research Assistance
